Tag: Association
ZOFRAN (ondansetron) – Association with Changes in Electrical Activity in the Heart
A new study shows that the anti-nausea drug ZOFRAN (ondansetron) can affect the electrical activity in the heart when used at high doses. The maximum intravenous dose of ZOFRAN is being lowered. Healthcare professionals and the public are being advised of this risk. Health Canada RSS – MedEffect Canada – Advisories and Recalls for Health [...]
ZOFRAN (ondansetron) – Association with Changes in Electrical Activity in the Heart
A new study shows that the anti-nausea drug ZOFRAN (ondansetron) can affect the electrical activity in the heart when used at high doses. The maximum intravenous dose of ZOFRAN is being lowered. Healthcare professionals and the public are being advised of this risk. Health Canada RSS – MedEffect Canada – Advisories and Recalls for the [...]
Record of Decisions – November 29, 2011, Canadian Consumer Specialty Products Association (CCSPA)
TPD meets with various Associations on a regular basis to ensure that information pertinent to the health of Canadians is communicated between TPD, industry, researchers and representatives from the health care community. Health Canada RSS – Drug Products, Drugs and Health Products
Trial watch: Genetic association studies link interleukin-6 receptor to coronary heart disease
Trial watch: Genetic association studies link interleukin-6 receptor to coronary heart disease Nature Reviews Drug Discovery 11, 342 (2012). doi:10.1038/nrd3737 Author: Charlotte Harrison Two studies published in The Lancet indicate that the interleukin-6 receptor (IL-6R) has a causal role in the development of coronary heart disease (Lancet379, 1214–1224; 2012; Lancet379, 1205–1213; 2012).IL-6 is a pro-inflammatory [...]
Benlysta (belimumab) – Association with hypersensitivity and infusion reactions
Cases of severe, sometimes fatal, delayed hypersensitivity reactions, associated with Benlysta (belimumab) treatment have been reported in patients with systemic lupus erythematosus. Health Canada RSS – MedEffect Canada – Advisories and Recalls for the Public
Benlysta (belimumab) – Association with Hypersensitivity and Infusion Reactions
Cases of severe, sometimes fatal, delayed hypersensitivity reactions, associated with Benlysta (belimumab) treatment have been reported in patients with systemic lupus erythematosus. Health Canada RSS – MedEffect Canada – Advisories and Recalls for Health Professionals
Revlimid (lenalidomide) – Association with an Increased Risk of Second Cancers
Health Canada has reviewed new safety information on the anti-cancer drug REVLIMID. The label has been updated to reflect the possible increased risk of second cancers in patients receiving REVLIMID for the treatment of multiple myeloma. Health Canada RSS – MedEffect Canada – Advisories and Recalls for Health Professionals
Revlimid (lenalidomide) – Association with an Increased Risk of Second Cancers
Health Canada has reviewed new safety information on the anti-cancer drug REVLIMID. The label has been updated to reflect the possible increased risk of second cancers in patients receiving REVLIMID for the treatment of multiple myeloma. Health Canada RSS – MedEffect Canada – Advisories and Recalls for the Public
